Wiley Encyclopedia of Clinical Trials Now Available
News Jan 22, 2009
From helping regulatory authorities to decide whether to approve a drug for use in their country to assisting health professionals making decisions about prescribing treatment, clinical trials are critical when it comes to determining the safety and effectiveness of a drug or treatment and discovering any side effects.
For those working in the medical community therefore, it is vital that they have quick and easy access to the most advanced and up-to-date information available, allowing them to see how a treatment works, how it compares to other therapies and what choices are best for their patients best. But, where to look?
The only major reference work devoted to this crucial area of medical research, the Wiley Encyclopedia of Clinical Trials is a unique and world-class compendium of basic concepts, methodologies and applications in clinical trials. Divided into four volumes and including more than 1,200 A-Z entries, this up-to-date and comprehensive work covers all aspects of the trial from basic statistical concepts to design and analysis, genetics to regulatory issues, ethics to safety and toxicity.
Special prominence is placed on current and emerging clinical issues, newly developed statistical methods, and reviews of statistical methodologies in various therapeutic surroundings.
Written by 600 of the worlds leading specialists working in corporate, pharmaceutical and academic environments, including Robert J. Gray to Sylvie Chev, Alon Z. Weizer and Chris Stevenson, the Wiley Encyclopedia of Clinical Trials incorporates a wealth of valuable information on a wide range of clinical trials, from cardiovascular to pulmonary, reproductive to urological. Meticulously compiled and unrivalled in breadth and scope, this is a must-have reference tool for anyone working in the field of medical research.
Ralph B. D’Agostino is Professor of Mathematics and Statistics and Executive Director, Graduate Program in Biostatistics at Boston University. He is the lead editor of the journal Statistics in Medicine and author and co-author of many books in biostatistics. Lisa M. Sullivan is Associate Dean for Undergraduate Education and Associate Professor of Biostatistics at Boston University. Joseph M. Massaro is Assistant Professor of Biostatistics, also at Boston University.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.